Literature DB >> 26835303

Treatment of children and adolescents with Hodgkin's Lymphoma without radiotherapy for patients in complete remission after chemotherapy.

Angelo Michele Carella1.   

Abstract

Entities:  

Year:  2013        PMID： 26835303      PMCID： PMC4728928          DOI： 10.3978/j.issn.2224-4336.2013.05.01

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  7 in total

1.  POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.

Authors:  Faith H Kung; Cindy L Schwartz; Carolyn R Ferree; Wendy B London; Jessie L Ternberg; Fred G Behm; Moody D Wharam; John M Falletta; Pedro de Alarcon; Allen R Chauvenet
Journal:  J Pediatr Hematol Oncol       Date:  2006-06       Impact factor: 1.289

2.  Treatment of advanced Hodgkin lymphoma: the more things change, the more they stay the same.

Authors:  Dan L Longo
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

3.  Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.

Authors:  H van den Berg; W Stuve; H Behrendt
Journal:  Med Pediatr Oncol       Date:  1997-07

4.  Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Authors:  James B Nachman; Richard Sposto; Philip Herzog; Gerald S Gilchrist; Suzanne L Wolden; John Thomson; Marshall E Kadin; Paul Pattengale; P Charlton Davis; Raymond J Hutchinson; Keith White
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

5.  Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.

Authors:  Friederike G A J Hakvoort-Cammel; Saskia Buitendijk; Marry van den Heuvel-Eibrink; Karel Hählen
Journal:  Pediatr Blood Cancer       Date:  2004-07       Impact factor: 3.167

6.  Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.

Authors:  I Yaniv; A Saab; I J Cohen; Y Goshen; D Loven; B Stark; H Tamary; R Zaizov
Journal:  J Pediatr Hematol Oncol       Date:  1996-02       Impact factor: 1.289

7.  Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

Authors:  Wolfgang Dörffel; Ursula Rühl; Heike Lüders; Alexander Claviez; Marion Albrecht; Jos Bökkerink; Harald Holte; Jonas Karlen; Georg Mann; Heinz Marciniak; Felix Niggli; Kjeld Schmiegelow; Ernst-Wilhelm Schwarze; Richard Pötter; Lutz Wickmann; Günther Schellong
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.